Stock News and Filings Feed


Add IDT
to your dashboard

ANI Pharmaceuticals Valued Cheaply Ahead Of Re-Commercialization Of Corticotropin Products

2017-08-17 seekingalpha
ANI Pharmaceuticals has a portfolio of 52 approved but discontinued products, with combined addressable market worth $3.7 billion.

IDT Corporation: Revisiting The Sum-Of-The-Parts Ahead Of The Upcoming Spin-Off

2017-08-17 seekingalpha
IDT Corporation is planning to spin-off its real estate, pharma assets and excess cash to shareholders in Q4 2017. IDT is trading at $15 with a $375m market cap.

IDT's Newest Clock Generator is up to 60% More Energy Efficient than other Comparable Solutions

2017-08-15 marketwired
The New 1.8V Version of the Leading VersaClock® 3S Programmable Clock Generator Delivers a Compelling Blend of Performance, Power and Flexibility to Consumer and Computing Systems

Tracking Kahn Brothers Portfolio - Q2 2017 Update

2017-08-09 seekingalpha
The portfolio continues to be very concentrated with the top five positions accounting for ~43% of the 13F holdings.

Top Yield Communication Services Dividend Dog Is Windstream As Of Aug. 1

2017-08-04 seekingalpha
Windstream led July/August Communication Services dividend dogs by yield and estimated net gains, as calculated 8/1/17.

IDT Expands Sensor Portfolio with Solid-State Flow Sensor Modules for Liquids and Gases

2017-07-25 marketwired
MEMS-based Digital Flow Sensor with Silicon-Carbide Coating is Industry's Most Robust and Reliable Solution Also Compatible with Food-Grade Applications

IDT Selects Four Recipients for Scholarships in Silicon Valley

2017-07-10 marketwired
SAN JOSE, CALIFORNIA--(Marketwired - July 10, 2017) - Integrated Device Technology, Inc. (IDT) (NASDAQ:IDTI) today announced that it has selected four young, deserving students who will each receive the IDT STEM Scholarship to help finance their post-secondary studies. IDT's "Acts of Giving" corporate responsibility initiative partners with local organizations that make a difference by providing guidance and support to young people who face varying degrees of challenges.

IDT's Flexible Timing Solution Provides Valuable Design Margin for 10Gbps, and 40/100Gbps Multi-lane Interfaces

2017-07-05 marketwired
Highly-Programmable Clock Generator and Jitter Attenuator IC Features sub-200fs Phase Noise to Ease Design Constraints and Lower Total System Costs

IDT Selected to Provide High-Efficiency Wireless Power Solution for LG's Latest Flagship Smartphone, G6

2017-06-27 marketwired
The Latest Version of the Company's Flagship Smartphone is a Sleek Feature-Rich Device that Brings the Convenience of Wireless Charging

Earnings Highlights and Review: 8x8's Revenue Jumped 16%; Adjusted EPS Soared 66.7%

2017-06-20 accesswire
LONDON, UK / ACCESSWIRE / June 20, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on 8x8, Inc. (NASDAQ: EGHT), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=EGHT, following the Company's posting of its fourth quarter and fiscal 2017 financial results on May 25, 2017. The telecommunications services Company outperformed top- and bottom-line expectations.

Why the Cuban Dream May Be Over for U.S. Telecom Operators

2017-06-19 zacks
President Donald Trump recently announced that his administration will do away with many policies related to the communist state of Cuba, taken by his predecessor, Barak Obama. As a result, the previous regime’s decision to normalize U.S. diplomatic and economic relations with Cuba, which has been considerably strained since 1961, is under threat once again.

Samsung Galaxy S8 Selects IDT High-Efficiency Wireless Power Solution

2017-06-13 marketwired
SAN JOSE, CALIFORNIA--(Marketwired - June 13, 2017) - Integrated Device Technology, Inc. (IDT) (NASDAQ:IDTI) today announced that IDT and Samsung have re-teamed to deliver fast wireless charging for Samsung's state-of-the-art, slim profile Galaxy S8 and S8+ models. This advanced IDT® technology includes all of the hardware and software needed to charge mobile devices wirelessly, without a wired connection, enabling Samsung's fast charge technology.

Fusion and XComIP to Form Joint Venture to Launch Fusion Global Services, LLC

2017-06-12 marketwired
Enhances Fusion's Focus on Business Services Segment, Improves Carrier Services' Margin Profile and Reduces Operating Expenses

IDT's (IDT) CEO Shmuel Jonas on Q3 2017 Results - Earnings Call Transcript

2017-06-06 seekingalpha
Good morning and welcome to the IDT Corporation’s Third Quarter Fiscal Year 2017 Earnings Call. During management’s prepared remarks, all participants will be in listen-only mode. [Operator Instructions] After today’s presentation by IDT’s management, there will be an opportunity to ask questions. [Operator Instructions]

IDT Corporation to Report Third Quarter Fiscal Year 2017 Results

2017-05-26 prnewswire
NEWARK, N.J., May 26, 2017 /PRNewswire/ -- IDT Corporation (NYSE: IDT), a global provider of communications and payment services, has scheduled its report of third quarter fiscal year 2017 financial and operational results for Tuesday, June 6, 2017.

IDW Media Holdings Names Stephen R. Brown to Board of Directors

2017-05-26 marketwired
STAMFORD, CT and SAN DIEGO, CA--(Marketwired - May 26, 2017) - IDW Media Holdings, Inc. (OTCQX: IDWM) is pleased to announce that, on May 22, 2017, Stephen R. Brown joined its Board of Directors. Since October 2016, Mr. Brown has served as the President of GMA Fund, LLC, a specialty finance company, and, since February 2015, has served as the Chief Financial Officer of Nanovibronix, Inc. (OTCBB: NAOV).

IDT Corporation Gained 20% in April -- But Shares Are Down in 2017

2017-05-09 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.

Tracking Kahn Brothers Portfolio - Q1 2017 Update

2017-05-09 seekingalpha
The portfolio continues to be very concentrated, with the top five positions accounting for ~46% of the 13F holdings.

ANI Pharmaceuticals' (ANIP) CEO Arthur Przybyl on Q1 2017 Results - Earnings Call Transcript

2017-05-04 seekingalpha
Good morning everyone. And welcome to the ANI's First Quarter 2017 Earnings Conference Call. At this time, all participants are in a listen only mode. Later you will have the opportunity to ask questions during the question-and-answer session. [Operator Instructions]. Please note this call may be recorded.

3
shares
ASX slips for a third day

2016-11-03 smh.com.au
Investors tentatively bought up oversold shares, but the bargain hunting wasn't enough to lift the overall market, which posted a third day of losses amid worries over the outcome of the US presidential election.

ASX slips for a third day

2016-11-03 theage.com.au
Investors tentatively bought up oversold shares, but the bargain hunting wasn't enough to lift the overall market, which posted a third day of losses amid worries over the outcome of the US presidential election.

IDT Australia to pocket $15M from divesting clinical trial business

2016-10-30 proactiveinvestors.com.au
IDT’s shares were last trading at $0.235, up 9.3% intraday. CMAX offers a full suite of clinical trial services including Phase I clinical trial management and delivery plus recruitment in specific disease states for Phase II and Phase III trials. IDT will receive a minimum $14 million in consideration for the CMAX business in a staged transaction. As part of the deal, IDT will establish and integrate the CMAX business within a new company.

IDT Australia Divests CMAX Clinical Trial Business to I'rom Group Co. Ltd

2016-10-28 prnewswire
- IDT to divest its Clinical Trial business "CMAX" to Japanese integrated healthcare company I'rom Group Co. Ltd ("I'rom Group") - IDT to receive a minimum of AU$14,000,000 in consideration, with the potential for this figure to increase based on an earn-out provision for the final consideration payment - Divestment will sharpen IDT's focus on its specialty generic strategy, proceeds will be used to support and drive this process

1
share
IDT Australia Ltd to reveal transaction

2016-10-26 proactiveinvestors.com.au
IDT Australia Ltd (ASX:IDT) has been granted a trading halt by the ASX, pending details of a possible corporate transaction.

InCarda Therapeutics Initiates Enrollment of Phase 1 Clinical Trial of Inhaled Flecainide for the Treatment of Cardiac Arrhythmias

2016-08-31 prnewswire
SAN FRANCISCO, Aug. 31, 2016 /PRNewswire/ -- InCarda Therapeutics, Inc. (InCarda), a privately-held biopharmaceutical company pioneering a novel approach of treating cardiovascular conditions by delivering medications via the inhalation route, today announced that it has initiated a Phase 1 clinical trial for its lead product intended to treat recent onset atrial fibrillation (AF).  The single-center trial will evaluate the safety and tolerability of inhaled flecainide in a randomized, double-blind, placebo-controlled design consisting of single ascending doses of inhaled active solution, or inhaled placebo solution, in multiple cohorts of healthy volunteers.

Fintel IR - Find the Right Investors for Your Company, Instantly!

Fintel IR combines the comprehensive Fintel ownership database with machine learning to provide advanced tools to make investor outreach fast and easy. Learn more now!